Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial:
Gespeichert in:
| Beteiligte Personen: | , , , , , , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | Englisch |
| Veröffentlicht: |
Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg
2017
|
| Schlagwörter: | |
| Links: | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-106024 http://d-nb.info/1187523194/34 https://open.fau.de/handle/openfau/10602 |
| Beschreibung: | Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich |
| Umfang: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045950026 | ||
| 003 | DE-604 | ||
| 005 | 20190722 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190625s2017 gw o|||| 00||| eng d | ||
| 015 | |a 19,O06 |2 dnb | ||
| 016 | 7 | |a 1187523194 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-106024 |2 urn | |
| 035 | |a (OCoLC)1101912452 | ||
| 035 | |a (DE-599)DNB1187523194 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Mc Causland, Finnian R. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial |c Finnian R. Mc Causland, Brian Claggett, Marc A. Pfeffer, Emmanuel A. Burdmann, Kai-Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert D. Tot, Patrick Parfrey |
| 264 | 1 | |a Erlangen |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2017 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 653 | |a Anemia | ||
| 653 | |a Hemoglobin | ||
| 653 | |a C-reactive protein End-stage renal disease Type 2 diabetes mellitus | ||
| 653 | |a Chronic kidney disease | ||
| 700 | 1 | |a Claggett, Brian |e Verfasser |4 aut | |
| 700 | 1 | |a Pfeffer, Marc A. |e Verfasser |4 aut | |
| 700 | 1 | |a Burdmann, Emmanuel A. |e Verfasser |4 aut | |
| 700 | 1 | |a Eckardt, Kai-Uwe |d 1960- |e Verfasser |0 (DE-588)110507835 |4 aut | |
| 700 | 1 | |a Levey, Andrew S. |e Verfasser |4 aut | |
| 700 | 1 | |a McMurray, John JV |e Verfasser |4 aut | |
| 700 | 1 | |a Remuzzi, Giuseppe |d 1949- |e Verfasser |0 (DE-588)1137964952 |4 aut | |
| 700 | 1 | |a Singh, Ajay K. |e Verfasser |0 (DE-588)142121053 |4 aut | |
| 700 | 1 | |a Solomon, Scott D. |e Verfasser |4 aut | |
| 700 | 1 | |a Tot, Robert D. |e Verfasser |4 aut | |
| 700 | 1 | |a Parfrey, Patrick S. |d 1950- |e Verfasser |0 (DE-588)1089687540 |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t American journal of nephrology |g 46 (2017), Seite 488–497 |o 10.1159/000485326 |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-106024 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1187523194/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/10602 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 347 | |b PDF | ||
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-031332137 | |
Datensatz im Suchindex
| _version_ | 1818985727434686464 |
|---|---|
| any_adam_object | |
| author | Mc Causland, Finnian R. Claggett, Brian Pfeffer, Marc A. Burdmann, Emmanuel A. Eckardt, Kai-Uwe 1960- Levey, Andrew S. McMurray, John JV Remuzzi, Giuseppe 1949- Singh, Ajay K. Solomon, Scott D. Tot, Robert D. Parfrey, Patrick S. 1950- |
| author_GND | (DE-588)110507835 (DE-588)1137964952 (DE-588)142121053 (DE-588)1089687540 |
| author_facet | Mc Causland, Finnian R. Claggett, Brian Pfeffer, Marc A. Burdmann, Emmanuel A. Eckardt, Kai-Uwe 1960- Levey, Andrew S. McMurray, John JV Remuzzi, Giuseppe 1949- Singh, Ajay K. Solomon, Scott D. Tot, Robert D. Parfrey, Patrick S. 1950- |
| author_role | aut aut aut aut aut aut aut aut aut aut aut aut |
| author_sort | Mc Causland, Finnian R. |
| author_variant | c f r m cfr cfrm b c bc m a p ma map e a b ea eab k u e kue a s l as asl j j m jj jjm g r gr a k s ak aks s d s sd sds r d t rd rdt p s p ps psp |
| building | Verbundindex |
| bvnumber | BV045950026 |
| collection | ebook |
| ctrlnum | (OCoLC)1101912452 (DE-599)DNB1187523194 |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02725nam a2200577zc 4500</leader><controlfield tag="001">BV045950026</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190722 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190625s2017 gw o|||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">19,O06</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1187523194</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-106024</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1101912452</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1187523194</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mc Causland, Finnian R.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial</subfield><subfield code="c">Finnian R. Mc Causland, Brian Claggett, Marc A. Pfeffer, Emmanuel A. Burdmann, Kai-Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert D. Tot, Patrick Parfrey</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Anemia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Hemoglobin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">C-reactive protein End-stage renal disease Type 2 diabetes mellitus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Chronic kidney disease</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claggett, Brian</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pfeffer, Marc A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burdmann, Emmanuel A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Eckardt, Kai-Uwe</subfield><subfield code="d">1960-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)110507835</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Levey, Andrew S.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McMurray, John JV</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Remuzzi, Giuseppe</subfield><subfield code="d">1949-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1137964952</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Singh, Ajay K.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)142121053</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Solomon, Scott D.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tot, Robert D.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Parfrey, Patrick S.</subfield><subfield code="d">1950-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1089687540</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">American journal of nephrology</subfield><subfield code="g">46 (2017), Seite 488–497</subfield><subfield code="o">10.1159/000485326</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-106024</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1187523194/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/10602</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="347" ind1=" " ind2=" "><subfield code="b">PDF</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031332137</subfield></datafield></record></collection> |
| id | DE-604.BV045950026 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-20T18:39:30Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031332137 |
| oclc_num | 1101912452 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | Mc Causland, Finnian R. Verfasser aut Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial Finnian R. Mc Causland, Brian Claggett, Marc A. Pfeffer, Emmanuel A. Burdmann, Kai-Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert D. Tot, Patrick Parfrey Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg 2017 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager Anemia Hemoglobin C-reactive protein End-stage renal disease Type 2 diabetes mellitus Chronic kidney disease Claggett, Brian Verfasser aut Pfeffer, Marc A. Verfasser aut Burdmann, Emmanuel A. Verfasser aut Eckardt, Kai-Uwe 1960- Verfasser (DE-588)110507835 aut Levey, Andrew S. Verfasser aut McMurray, John JV Verfasser aut Remuzzi, Giuseppe 1949- Verfasser (DE-588)1137964952 aut Singh, Ajay K. Verfasser (DE-588)142121053 aut Solomon, Scott D. Verfasser aut Tot, Robert D. Verfasser aut Parfrey, Patrick S. 1950- Verfasser (DE-588)1089687540 aut Sonderdruck aus American journal of nephrology 46 (2017), Seite 488–497 10.1159/000485326 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-106024 Resolving-System kostenfrei Volltext http://d-nb.info/1187523194/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/10602 Verlag kostenfrei Volltext |
| spellingShingle | Mc Causland, Finnian R. Claggett, Brian Pfeffer, Marc A. Burdmann, Emmanuel A. Eckardt, Kai-Uwe 1960- Levey, Andrew S. McMurray, John JV Remuzzi, Giuseppe 1949- Singh, Ajay K. Solomon, Scott D. Tot, Robert D. Parfrey, Patrick S. 1950- Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial |
| title | Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial |
| title_auth | Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial |
| title_exact_search | Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial |
| title_full | Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial Finnian R. Mc Causland, Brian Claggett, Marc A. Pfeffer, Emmanuel A. Burdmann, Kai-Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert D. Tot, Patrick Parfrey |
| title_fullStr | Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial Finnian R. Mc Causland, Brian Claggett, Marc A. Pfeffer, Emmanuel A. Burdmann, Kai-Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert D. Tot, Patrick Parfrey |
| title_full_unstemmed | Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial Finnian R. Mc Causland, Brian Claggett, Marc A. Pfeffer, Emmanuel A. Burdmann, Kai-Uwe Eckardt, Andrew S. Levey, John J.V. McMurray, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert D. Tot, Patrick Parfrey |
| title_short | Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial |
| title_sort | change in hemoglobin trajectory and darbepoetin dose approaching end stage renal disease data from the trial to reduce cardiovascular events with aranesp therapy trial |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-106024 http://d-nb.info/1187523194/34 https://open.fau.de/handle/openfau/10602 |
| work_keys_str_mv | AT mccauslandfinnianr changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT claggettbrian changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT pfeffermarca changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT burdmannemmanuela changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT eckardtkaiuwe changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT leveyandrews changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT mcmurrayjohnjv changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT remuzzigiuseppe changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT singhajayk changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT solomonscottd changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT totrobertd changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial AT parfreypatricks changeinhemoglobintrajectoryanddarbepoetindoseapproachingendstagerenaldiseasedatafromthetrialtoreducecardiovasculareventswitharanesptherapytrial |